The CEDAR Study: A Longitudinal Study of the Clinical Effects of Conventional DMARDs and Biologic DMARDs in Australian Rheumatology Practice

Table 4

EULAR responses.

EULAR response; (%)	Methotrexate	Hydroxychloroquine	Leflunomide	Sulfasalazine	Etanercept	Adalimumab	Tocilizumab	Abatacept	Rituximab
Good
Moderate
No response